Florida Drugmaker Draws FDA Warning for Repackaging

Drug GMP Report
A A
The FDA warned Phase 4 Pharmaceutical for repackaging deficiencies and the lack of procedures for drug distribution at its Aventura, Florida facility.

To View This Article:

Login

Subscribe To Drug GMP Report